171 related articles for article (PubMed ID: 24906539)
1. Adenocarcinoma of the ampulla of Vater: what treatment options are available?
Senatore FJ; Ynson ML; Dasanu CA
J Oncol Pharm Pract; 2015 Oct; 21(5):364-9. PubMed ID: 24906539
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.
Kim ST; Lee J; Lee KT; Lee JK; Lee KH; Choi SH; Heo JS; Choi DW; Park SH; Park JO; Lim HY; Park YS; Kang WK
Med Oncol; 2010 Dec; 27(4):1149-54. PubMed ID: 19898973
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
Overman MJ; Varadhachary GR; Kopetz S; Adinin R; Lin E; Morris JS; Eng C; Abbruzzese JL; Wolff RA
J Clin Oncol; 2009 Jun; 27(16):2598-603. PubMed ID: 19164203
[TBL] [Abstract][Full Text] [Related]
4. Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.
Kim HS; Shin SJ; Kim JH; Kim H; Choi HJ
Tohoku J Exp Med; 2013 Sep; 231(1):21-8. PubMed ID: 23994910
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?
Amptoulach S; Josefsson A; Kavantzas N; Kalaitzakis E
Scand J Gastroenterol; 2011 Nov; 46(11):1401-3. PubMed ID: 21854095
[No Abstract] [Full Text] [Related]
6. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Neoptolemos JP; Moore MJ; Cox TF; Valle JW; Palmer DH; McDonald AC; Carter R; Tebbutt NC; Dervenis C; Smith D; Glimelius B; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Ghaneh P; Halloran CM; Lerch MM; Oláh A; Rawcliffe CL; Verbeke CS; Campbell F; Büchler MW;
JAMA; 2012 Jul; 308(2):147-56. PubMed ID: 22782416
[TBL] [Abstract][Full Text] [Related]
7. Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy.
Shoji H; Morizane C; Hiraoka N; Kondo S; Ueno H; Ohno I; Shimizu S; Mitsunaga S; Ikeda M; Okusaka T
Jpn J Clin Oncol; 2014 Apr; 44(4):324-30. PubMed ID: 24482413
[TBL] [Abstract][Full Text] [Related]
8. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
[TBL] [Abstract][Full Text] [Related]
9. A collision tumor composed of cancers of the bile duct and ampulla of Vater--immunohistochemical analysis of a rare entity of double cancer.
Hirono S; Tani M; Terasawa H; Kawai M; Ina S; Uchiyama K; Nakamura Y; Kakudo K; Yamaue H
Hepatogastroenterology; 2008; 55(84):861-4. PubMed ID: 18705284
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
11. Time to move to targeted drugs in biliary tract cancer?
Louvet C; Tournigand C
Onkologie; 2010; 33(1-2):10-1. PubMed ID: 20164655
[No Abstract] [Full Text] [Related]
12. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study.
Moekotte AL; Malleo G; van Roessel S; Bonds M; Halimi A; Zarantonello L; Napoli N; Dreyer SB; Wellner UF; Bolm L; Mavroeidis VK; Robinson S; Khalil K; Ferraro D; Mortimer MC; Harris S; Al-Sarireh B; Fusai GK; Roberts KJ; Fontana M; White SA; Soonawalla Z; Jamieson NB; Boggi U; Alseidi A; Shablak A; Wilmink JW; Primrose JN; Salvia R; Bassi C; Besselink MG; Abu Hilal M
Br J Surg; 2020 Aug; 107(9):1171-1182. PubMed ID: 32259295
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma in adenoma of the papilla of Vater.
Uchida Y; Tomonari K; Shibata O; Hadama T; Shirabe J; Matsumoto K; Yokoyama S
Jpn J Surg; 1986 Sep; 16(5):371-6. PubMed ID: 3795632
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Resected Lymph Node Recurrence of Cancer of the Papilla of Vater].
Harano R; Kusashio K; Yasutomi J; Matsumoto M; Suzuki M; Iida A; Irabu S; Imamura N; Shirokane D; Udagawa I
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1579-81. PubMed ID: 26805102
[TBL] [Abstract][Full Text] [Related]
15. Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):436-41. PubMed ID: 19394162
[TBL] [Abstract][Full Text] [Related]
16. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
17. Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.
Aburjania N; Truskinovsky AM; Overman MJ; Lou E
J Gastrointest Cancer; 2014 Mar; 45(1):87-90. PubMed ID: 23417715
[No Abstract] [Full Text] [Related]
18. Adenocarcinoma of the ampulla of Vater metastasising into the right ventricle.
Moser M; Wiedemann D; Kitzwögerer M; Frank H
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27060070
[TBL] [Abstract][Full Text] [Related]
19. Early occurrence of chylothorax related to thoracic irradiation and concomitant chemotherapy.
Chang PY; Chao TY; Dai MS
Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):291. PubMed ID: 15997925
[No Abstract] [Full Text] [Related]
20. Long-term survival of a patient with neuroendocrine carcinoma of the ampulla of vater with lymph node micrometastasis.
Watanabe Y; Yamada D; Ogawa Y; Fujino M; Kobayashi K; Ryu S; Tanaka M
Am Surg; 2013 May; 79(5):E199-201. PubMed ID: 23635569
[No Abstract] [Full Text] [Related]
[Next] [New Search]